Location: Houston
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Houston
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Phase 1/Phase 2 · MD Anderson · Eikon Therapeutics · NCT06907043To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Phase 3 · Biomed Testing Facility #BIO-19-77030 · Biomed Industries, Inc. · NCT06840496The PREDICT Registry:
Phase N/A · Baylor College of Medicine · PreludeDx · NCT03448926Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 · University of Texas MD Anderson Cancer Center · USWM CT, LLC · NCT03391778A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · Integrity Advanced Therapeutics PLLC · Hoffmann-La Roche · NCT06588855Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · MD Anderson Cancer Center · Corvus Pharmaceuticals, Inc. · NCT06561048Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06961968First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia
Phase 1 · Texas Children's Hospital · Allterum Therapeutics, Inc · NCT07586618Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NA · M D Anderson Cancer Center · M.D. Anderson Cancer Center · NCT02361320Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Phase 1 · MD Anderson Cancer Center · Stelexis BioSciences · NCT06533761A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Houston Metro Urology · Janssen Research & Development, LLC · NCT06319820TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07223203A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Phase 1/Phase 2 · The University of Texas MD Anderson Cancer Center- Site Numb · Sanofi · NCT05584670Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · UT Health University of Texas · Novo Nordisk A/S · NCT06612268A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · Baylor College of Medicine · Johns Hopkins University · NCT07059091Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Texas Children's Cancer Center · New York Blood Center · NCT01656603Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · Retina Consultants of Texas - (Houston) · IDEAYA Biosciences · NCT07015190Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Phase 1 · MD Anderson Cancer Center · M.D. Anderson Cancer Center · NCT06545682Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiograp
NA · The University of Texas Health Science Center at Houston · Santiago Ortega Gutierrez · NCT06825897Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHAS
NA · The University of Texas M. D. Anderson Cancer Center · M.D. Anderson Cancer Center · NCT06991062Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)
Phase 1/Phase 2 · Research Site · HuidaGene Therapeutics Co., Ltd. · NCT05906953Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · Baylor College of Medicine Medical Center · GOG Foundation · NCT05659381A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodyspl
Phase 1/Phase 2 · MD Anderson Cancer Center · M.D. Anderson Cancer Center · NCT06548230Atropine Eye Drops for Watery Eyes (Excessive Tearing)
Phase 2 · Greater Houston Eye Consultants · Rehan Ahmed · NCT07676981Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · HDH Research Inc · Philip Morris Products S.A. · NCT07108166Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Texas Children's Hospital /ID# 238304 · AbbVie · NCT03339128A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · MD Anderson Cancer Center · Crossignal Therapeutics, Inc. · NCT06598007EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combinatio
Phase 1/Phase 2 · University of Texas MD Anderson Cancer Center · Eikon Therapeutics · NCT07262619
Look up another city
Look up another condition